Comparison between ANG Lifesciences IPO and Pashupati Cotspin IPO.
ANG Lifesciences IPO is a SME Fixed Price IPO proposed to list at BSE SME while Pashupati Cotspin IPO is a SME Fixed Price proposed to list at NSE SME.
| ANG Lifesciences IPO | Pashupati Cotspin IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Oneview Corporate Advisors Pvt.Ltd. | Hem Securities Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Sharex Dynamic (India) Pvt.Ltd. |
| Market Maker | Guiness Securities Ltd. | Monarch Networth Capital Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
The total issue size of ANG Lifesciences IPO is up to ₹11.39 Cr whereas the issue size of the Pashupati Cotspin IPO is up to ₹19.34 Cr. The final issue price of ANG Lifesciences IPO is ₹80.00 per share and of Pashupati Cotspin IPO is ₹75.00 per share.
| ANG Lifesciences IPO | Pashupati Cotspin IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹80.00 per share | ₹75.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 1600 shares |
| Fresh Issue Size | 14,24,000 shares | 25,79,200 shares |
| Fresh Issue Size (Amount) | up to ₹11.39 Cr | up to ₹19.34 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 14,24,000 shares | 25,79,200 shares |
| Issue Size Total (Amount) | up to ₹11.39 Cr | up to ₹19.34 Cr |
ANG Lifesciences IPO opens on Aug 29, 2017, while Pashupati Cotspin IPO opens on Aug 28, 2017. The closing date of ANG Lifesciences IPO and Pashupati Cotspin IPO is Aug 31, 2017, and Aug 31, 2017, respectively.
| ANG Lifesciences IPO | Pashupati Cotspin IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 29, 2017 | Aug 28, 2017 |
| Issue Close | Aug 31, 2017 | Aug 31, 2017 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Sep 08, 2017 | Sep 08, 2017 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
ANG Lifesciences IPO P/E ratio is , as compared to Pashupati Cotspin IPO P/E ratio of .
| ANG Lifesciences IPO | Pashupati Cotspin IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | ||||||
| Promoter Shareholding (Post-Issue) | ||||||
| P/E Ratio | ||||||
| Market Cap | ₹41.47 Cr. | ₹42.00 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the ANG Lifesciences IPO Retail Individual Investors (RII) are offered 7,12,000 shares while in Pashupati Cotspin IPO retail investors are offered 7,12,000 shares. Qualified Institutional Buyers (QIB) are offered in ANG Lifesciences IPO and in Pashupati Cotspin IPO.
| ANG Lifesciences IPO | Pashupati Cotspin IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 76,800 shares | 2,04,800 shares |
| QIB | ||
| NII | 7,12,000 shares | 12,89,600 shares |
| RII | 7,12,000 shares | 12,89,600 shares |
| Employee | ||
| Others | ||
| Total | 14,24,000 shares | 25,79,200 shares |
ANG Lifesciences IPO subscribed 8.25x in total, whereas Pashupati Cotspin IPO subscribed 1.84x.
| ANG Lifesciences IPO | Pashupati Cotspin IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 5.13x | 2.01x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 11.36x | 1.68x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 8.25x | 1.84x |
